Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP76766.RAeVYmOiBD9Sz_TtoOLONKrCZu6EZdiKOzONPU2jXSIi0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP76766.RAeVYmOiBD9Sz_TtoOLONKrCZu6EZdiKOzONPU2jXSIi0130_assertion type Assertion NP76766.RAeVYmOiBD9Sz_TtoOLONKrCZu6EZdiKOzONPU2jXSIi0130_head.
- NP76766.RAeVYmOiBD9Sz_TtoOLONKrCZu6EZdiKOzONPU2jXSIi0130_assertion description "[BRAF genotype is correlated with PFS and OS in KRAS wild type mCRC patients, which is independent of cetuximab treatment. PIK3CA mutation, loss of PTEN expression, EGFR GCN and HER2 GCN have no predictive value for response to treatment with cetuximab, ne]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP76766.RAeVYmOiBD9Sz_TtoOLONKrCZu6EZdiKOzONPU2jXSIi0130_provenance.
- NP76766.RAeVYmOiBD9Sz_TtoOLONKrCZu6EZdiKOzONPU2jXSIi0130_assertion evidence source_evidence_literature NP76766.RAeVYmOiBD9Sz_TtoOLONKrCZu6EZdiKOzONPU2jXSIi0130_provenance.
- NP76766.RAeVYmOiBD9Sz_TtoOLONKrCZu6EZdiKOzONPU2jXSIi0130_assertion SIO_000772 20413299 NP76766.RAeVYmOiBD9Sz_TtoOLONKrCZu6EZdiKOzONPU2jXSIi0130_provenance.
- NP76766.RAeVYmOiBD9Sz_TtoOLONKrCZu6EZdiKOzONPU2jXSIi0130_assertion wasDerivedFrom gad-20150221 NP76766.RAeVYmOiBD9Sz_TtoOLONKrCZu6EZdiKOzONPU2jXSIi0130_provenance.
- NP76766.RAeVYmOiBD9Sz_TtoOLONKrCZu6EZdiKOzONPU2jXSIi0130_assertion wasGeneratedBy ECO_0000203 NP76766.RAeVYmOiBD9Sz_TtoOLONKrCZu6EZdiKOzONPU2jXSIi0130_provenance.